Autoimmune thyroiditis Part 1 - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)

Ulcerative Colitis - Pamela Smith, MD, MS (2021 Conference) (LDN, low dose naltrexone)

Treating Children’s Health in a Special Needs Pediatric Practice - Brian Udell, MD (2021 Conference) (LDN, low dose naltrexone)

Strategies for reducing excess body fat... - Jill Brook, MA (2021 Conference) (LDN, low dose naltrexone)

Rheumatology - Update 2021 - Edyta Biernat-Kaluza, MD, PhD (2021 Conference) (LDN, low dose naltrexone)

Reclaim the Lives of Lupus Patients, A Unique Treatment Approach - Deanna Windham, DO (2021 Conference) (LDN, low dose naltrexone)

PTSD and other mental health treatment with opioid antagonist... - Galyn Forster, MS, LPC (2021 Conference) (LDN, low dose naltrexone)

New approaches to managing fibromyalgia pain - Ginevra Liptan, MD (2021 Conference) (LDN, low dose naltrexone)

Multiple Sclerosis - The role of combination therapy of LDN and Testosterone ... - Harpal Bains, MD (2021 Conference) (LDN, low dose naltrexone)

Lyme Disease - Darin Ingels, ND (2021 Conference) (LDN, low dose naltrexone)